Actively Recruiting
Study of the Prevalence and Severity of Cutaneous Lupus Erythematosus in Adults
Led by University of Pennsylvania · Updated on 2026-03-30
700
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are collecting and analyzing data on Cutaneous Lupus Erythematosus CLE through a multi-site database established in 2006 between the University of Pennsylvania and the University of Texas Southwestern. This observational study gathers clinical information to better understand the disease process, treatments, and impact on patients quality of life. The database helps track the clinical course of CLE and provides valuable insights into photosensitivity and medication effects. The study incorporates the Cutaneous Lupus Activity and Severity Index CLASI, a validated tool used to measure disease activity and severity in patients with CLE. Along with surveys and other assessment tools, the database collects detailed patient information to monitor disease responsiveness and quality of life over time. This ongoing resource supports clinicians in evaluating evolving clinical changes and patient responses to various treatments. Participants contribute data through clinical assessments, surveys, and validated outcome measures like CLASI. The study monitors quality of life impacts and treatment outcomes continuously, enabling long-term observation of CLE. This research aims to improve understanding of CLEs clinical course and treatment response, with no intervention applied. Participation duration varies as data is collected over time to reflect disease progression and management.
CONDITIONS
Brief Title
Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus
Research Team
V
Victoria P Werth, MD
J
Joyce Okawa, R.N
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here